INSIGHTS FROM THE BRAIN TRUST

Complimentary Innovation

DEALFLOWUPDATE Issue #47. Thursday, December 23Hello Everyone,Happy holidays from me and the team. In what has been a great year for Zoic Capital, thank you for reading, subscribing and sharing with colleagues.For this edition of the Zoic newsletter, we'll be covering...

Liquid Biopsy and Deep Brain Stimulation

DEALFLOWUPDATE Issue #46. Wednesday, December 11Hello Everyone,For this edition of the Zoic newsletter, we'll be reviewing deals in the early blood testing space, neural modulating as well as a growing area that may not be a match for our metrics now, but soon could...

The Benefits of a Strong Device Platform

DEALFLOWUPDATEIssue #45. Wednesday, November 27Hello Everyone,For this edition of the Zoic newsletter, we'll be looking at deals that exist now that could all theoretically be addressed by the same blood testing platform. We've covered diagnostics many times, but this...

Healthcare Policy and The Microbiome Diagnostic Space

DEALFLOWUPDATEIssue #44. Monday, November 11Hello Everyone,For this edition of the Zoic deal newsletter, we'll be covering a range of diagnostics, devices and an important policy discussion taking place.Recently, I've been thinking about the debacle surrounding WeWork...

Innovative and Impactful Approach to Cancer

DEALFLOWUPDATEIssue #43. Friday, October 25Hello Everyone,For this edition of the Zoic newsletter, we'll be featuring technologies and companies that are all focused on cancer. Cancer is such a large potential market, with massive amounts of investment and research...

The Rise of Better Manufacturing Methods

DEALFLOWUPDATEIssue #42. Friday, October 11Hello Everyone,For this edition of the Zoic newsletter, we'll be featuring some previously mentioned areas of interest, as well as some new ones. These include early molecular diagnostics, better imaging, and tissue...

Join Zoic's Newsletter

Our team of industry experts and professionals provide industry news, guidance and perspective within the life sciences and medtech investment sectors. To see the type of deals and company innovation we pay attention to, consider receiving our biweekly deal flow newsletter.